TMCI
TREACE MEDICAL CONCEPTS, INC.
Latest Form 4:Purchase$177KbyTreace John T. (Chief Executive Officer) · filed Aug 24, 2026
TREACE MEDICAL CONCEPTS, INC. (TMCI) has 34 SEC Form 4 filings (52 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Aug 24, 2026.
Inside the rolling window, 1 insider at TREACE MEDICAL CONCEPTS, INC. reported 12 open-market purchases totaling $1.5M and no open-market sales. The most active filer is Chief Executive Officer Treace John T. with 12 filings. Insiders have net bought $1.5M over the trailing 6 months. The most recent open-market filing is a purchase of 39,944 shares by Chief Executive Officer Treace John T., dated Aug 20, 2026, worth $177K.
- Industry:Medical - Devices
- CEO:John T. Treace
- Employees:450
- HQ:Ponte Vedra, FL, US
- IPO:2021-04-23
Insider Buying
$1.5M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
1
in the rolling window
Market Cap
$299.2M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Executive Officer | Purchase | 39,944 | $177K | Aug 24 | SEC ↗ | |
| Chief Executive Officer | Purchase | 5,000 | $22K | Aug 24 | SEC ↗ | |
| Chief Executive Officer | Purchase | 11,000 | $48K | Aug 24 | SEC ↗ | |
| Chief Executive Officer | Purchase | 44,145 | $178K | Jun 12 | SEC ↗ | |
| Chief Executive Officer | Purchase | 32,778 | $133K | Jun 12 | SEC ↗ | |
| Chief Executive Officer | Purchase | 50,000 | $178K | Jun 1 | SEC ↗ | |
| Chief Executive Officer | Purchase | 4,508 | $13K | May 28 | SEC ↗ | |
| Chief Executive Officer | Purchase | 49,810 | $143K | May 28 | SEC ↗ | |
| Chief Executive Officer | Purchase | 61,202 | $185K | May 28 | SEC ↗ | |
Treace John T.First filing | Chief Executive Officer | Purchase | 43,000 | $93K | May 14 | SEC ↗ |
Treace John T.First filing | Chief Executive Officer | Purchase | 49,013 | $121K | May 14 | SEC ↗ |
Treace John T.First filing | Chief Executive Officer | Purchase | 61,750 | $161K | May 14 | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does TMCI have?
TREACE MEDICAL CONCEPTS, INC. (TMCI) has 34 SEC Form 4 filings (52 transaction rows) in the rolling 365-day window, disclosed by 1 distinct insider. Most recent filing: Aug 24, 2026.
When was the most recent SEC Form 4 filing for TMCI?
The most recent Form 4 filing for TMCI on Tracefour is dated Aug 24, 2026.
Who is the most active insider at TMCI?
The most active SEC Form 4 filer at TMCI in the rolling window is Chief Executive Officer Treace John T., with 12 filings.
What is the net insider flow at TMCI over the last 6 months?
Over the trailing 180 days, insiders at TMCI have net bought $1.5M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at TMCI in the current window?
Inside the rolling window, insiders at TMCI bought $1.5M and sold $0 based on SEC Form 4 filings.
Can I get alerts for TMCI insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at TREACE MEDICAL CONCEPTS, INC. (TMCI). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
TREACE MEDICAL CONCEPTS, INC. is in the Healthcare sector.